Trump is planning to impose tariffs on pharmaceutical imports, with the tariffs potentially reaching up to 250%. The tariffs are expected to be implemented, although the timing is not certain, with some reports suggesting they may be weeks away. The planned tariffs have sparked reaction from the pharmaceutical industry and raised concerns about their potential impact on patients.